Growth in Hims & Hers Health is showing no signs of stopping, according to Morgan Stanley.
Related Posts
CoreWeave prices IPO at $40 a share, below expected range
CoreWeave is trying to thaw the tech IPO market with one of the biggest offerings in years, but investors have expressed some skepticism.
Watch SpaceX launch Starship’s fourth flight of the year
SpaceX is set to attempt its sixth Starship test flight to date on Tuesday.
FTC Chair Khan hopes Amazon, Facebook won’t get ‘sweetheart deal’ from Trump in antitrust cases
Lina Khan, who was tapped by President Joe Biden to lead the FTC, is set to be replaced by President-elect Donald Trump’s pick Andrew Ferguson.